Effectiveness of oral antiviral agents on long‐term cardiovascular risk in nonhospitalized patients with COVID‐19: A multicenter matched cohort study

TH Liu, MH Chuang, JY Wu, PY Huang… - Journal of Medical …, 2023 - Wiley Online Library
Although a novel oral antiviral agent can improve short‐term COVID‐19 outcomes, its effects
on the long‐term outcomes, namely the risk of major adverse cardiovascular events …

Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19

JY Wu, MY Liu, TH Liu, MH Chuang… - Journal of Medical …, 2023 - Wiley Online Library
The aim of this study was to investigate the clinical efficacy of a combination of nirmatrelvir
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …

Using the concept of circular economy to reduce the environmental impact of COVID-19 face mask waste

EJ Hou, YY Hsieh, TW Hsu, CS Huang, YC Lee… - Sustainable Materials …, 2022 - Elsevier
COVID-19 pandemic has posed severe threats to the society globally. World Health
Organization (WHO) guidelines suggest that people wear face masks as a precautionary …

[HTML][HTML] Time trend and seasonality in medically attended respiratory syncytial virus (RSV) infections in US children aged 0–5 years, January 2010–January 2023

L Wang, N Berger, PB Davis, DC Kaelber… - Family Medicine and …, 2023 - ncbi.nlm.nih.gov
Objective The long-term time trend and seasonality variations of first-time medically attended
respiratory syncytial virus (RSV) infections among young children are unknown. We aim to …

Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID‐19 and substance use disorders based on real‐world data

TH Liu, PY Huang, JY Wu, MH Chuang… - Journal of Medical …, 2023 - Wiley Online Library
This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV‐r) in treating
patients with coronavirus disease‐2019 (COVID‐19) and substance use disorders (SUDs) …

Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review

U Bonnet, M Specka, P Roser, N Scherbaum - Journal of Neural …, 2023 - Springer
The interaction between cannabis use or addiction and SARS-COV-2 infection rates and
COVID-19 outcomes is obscure. As of 08/01/2022 among 57 evaluated epidemiological …

[HTML][HTML] Risk factors associated with SARS-CoV-2 breakthrough infections in fully mRNA-vaccinated individuals: Retrospective analysis

C Liu, J Lee, C Ta, A Soroush… - JMIR Public Health …, 2022 - publichealth.jmir.org
Background COVID-19 messenger RNA (mRNA) vaccines have demonstrated efficacy and
effectiveness in preventing symptomatic COVID-19, while being relatively safe in trial …

Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder

L Wang, ND Volkow, NA Berger… - Journal of Clinical …, 2023 - Wiley Online Library
Abstract Importance More than 109,000 Americans died of drug overdose in 2022, with
81,231 overdose deaths involving opioids. Methadone, buprenorphine and naltrexone are …

Association of aspirin use with reduced risk of developing Alzheimer's disease in elderly ischemic stroke patients: a retrospective cohort study

MP Gorenflo, PB Davis, EK Kendall… - Journal of …, 2023 - content.iospress.com
Background: Currently there are no effective therapies to prevent or halt the development of
Alzheimer's disease (AD). Multiple risk factors are involved in AD, including ischemic stroke …

COVID-19 pandemic, substance use disorders and body image issues, a worrisome correlation

S Zaami, A Sirignano, Ó García-Algar… - European review for …, 2022 - iris.uniroma1.it
The SARS-CoV-2 pandemic has profoundly affected the social fabric and the economic and
health care viability and functioning of most countries. Aside from its deeply destructive …